Abstract
THE QUANTITATIVE reverse transcriptase polymerase chain reaction allows accurate quantification of plasma viral load as the concentration of human immunodeficiency virus (HIV) RNA copies.1,2 Numerous studies3-8 that demonstrate the prognostic value of viral load measurements for disease progression have been published. Plasma viral load appears to be the best predictor of long-term clinical outcome, whereas CD4 cell counts predict clinical progression and survival in the shorter term.9-11 Although many randomized studies12 addressed the respective roles of viral load and CD4 cell counts, uncertainty still remains about the best use of these 2 markers outside controlled trials.

This publication has 26 references indexed in Scilit: